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Abstract  
Physical exercise is a strong external effector that induces precursor cell proliferation in the adult mouse hippocampus. 
Research into mechanisms has focused on central changes within the hippocampus and we have established that 
serotonin is the signaling factor that transduces physical activity into adult neurogenesis. Less focus has been given 
on potential peripheral signals that may cause pro-mitotic running effects. Vasoactive kinin peptides are important 
for blood pressure regulation and inflammatory processes to maintain cardiovascular homeostasis. Acting via the two 
receptors termed B1 (B1R) and B2R, the peptides also function in the brain. In particular, studies attribute B2R a role 
in cell proliferation and differentiation into neurons in vitro. Here, we determined B1R and B2R mRNA expression 
levels in the adult mouse hippocampus and prefrontal cortex in vivo, and in response to running exercise. Using mice 
depleted in either or both receptors, B1-knockout (KO), B2KO and B1/2KO we observed changes in running 
performance overnight and in running distances. However, voluntary exercise led to the known pro-mitotic effect in 
the dentate gyrus of B1KO mice while it was attenuated in B2KO accompanied by an increase in microglia cells. Our 
data identify B2R as important factor in running-induced precursor cell proliferation.  
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Introduction 
External stimuli and intrinsic factors modulate the generation of new neurons in the adult mouse dentate gyrus 
(Kempermann et al., 1997, van Praag et al., 1999, Klempin et al., 2013, Klempin et al., 2018). The niche’s intrinsic 
components are neurotransmitters, growth and neurotrophic factors, cell autonomous molecules and transcription 
factors with distinct effects on cell proliferation and differentiation (Goncalves et al., 2016). Bradykinin, an important 
mediator of cardiovascular homeostasis, has been identified to also function in the brain (Chen et al., 2000, Shughrue 
et al., 2003). Kinins, with the active peptide bradykinin, exert their effects via two G-protein-coupled receptors 
primarily known to mediate inflammatory processes by causing endogenous vasodilation (Marceau and Regoli, 
2004): Bradykinin B2 receptors (B2R) are abundant in the rat brain and exhibit high affinity to bradykinin. B1 
receptors (B1R) are relatively low expressed, synthesized de novo at sites of injury and inflammation (Ongali et al., 
2003), and interact with des-Arg9-bradikinin.  
Most of the physiological functions of kinins are mediated by B2R. In the central nervous system, bradykinin via 
B2R participates in signaling pathways for nitric oxide (NO) formation, glutamate release (Parpura et al., 1994, 
Kohno et al., 2008) and in the development of temporal lobe epilepsy (Perosa et al., 2007, Silva et al., 2008). In 
particular, B2R plays a role in cell proliferation and fate determination towards neurons as shown in mouse embryonic 
stem cell cultures, and B2R knockout rats (Trujillo et al., 2012, Nascimento et al., 2015, Pillat et al., 2016). 
Furthermore, B2R is involved in angiogenesis and gliogenesis at lesion sites following ischemic stroke, and promotes 
neurogenesis in cultured neuronal cells (Xia et al., 2006) – adding novel actions to kinins as neuropeptides (Negraes 
et al., 2015).  
Physical exercise is also neuroprotective and promotes the proliferative phase in adult neurogenesis (van Praag et al., 
1999). Given the potential role of kinin receptors in cell proliferation, we investigated B1R and B2R mRNA 
expression levels in the adult mouse brain in vivo at baseline, and after 6 days of voluntary running. We took 
advantage of mice depleted in either or both receptors, B1-knockout (KO), B2KO or B1/2KO, to study their effects 
in running-induced precursor cell proliferation. At baseline, our data show an overexpression of B1R mRNA in 
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absence of B2R, whereas running decreases B1R expression in the adult hippocampus of wild type [WT] mice. 
Absence of kinin receptors led to changes in running performance overnight in that mice are getting exhausted fast. 
Voluntary wheel running led to the known robust increase in cell proliferation in B1KO mice while it was attenuated 
in B2KO as well as B1/2KO mice. Furthermore, lack of B2R led to alterations in cell phenotype distribution and 
increased microglia cells upon exercise. Our data identify B2R as essential to running-induced precursor cell 
proliferation in the dentate gyrus.  
 
Materials and methods  
Adult female B1R-, B2R-deficient (B1KO, B2KO), double knockout (B1/2KO), and C57BL/6N WT matched mice 
were used in this study (n = 40, 8 to 12 weeks old). The generation of mice has been described in detail earlier 
(Borkowski et al., 1995, Pesquero et al., 2000, Cayla et al., 2007). Mice were randomly divided into two groups for 
“baseline” (2 to 3 animals per standard cage) and “running” conditions (single housed in a standard cage plus running 
wheel), and held with a 12 hours light/dark cycle and ad libitum access to food and water. Mice in running conditions 
had unlimited access to the running wheel for 6 days and running distance, time and performance was monitored 
daily (by both commercial bicycle computers and Tinytag Data Logger Chambers that allows monitoring the running 
performance per every 5 minutes). We have used single housing that allows examining the running performance per 
individual mouse. Others and we have previously reported that no isolation effects occur for different mouse strains 
(Marlatt et al., 2010, Klempin et al., 2013). To analyze proliferation, animals received three intraperitoneal injections 
(i.p.) of bromodeoxyuridine (BrdU, SIGMA-Aldrich, Germany; 50 mg/kg body weight dissolved in 0.9% NaCl) on 
day 6, 6 hours apart and were killed 24 hours after the first injection (Fig. 1a). All experiments were performed 
according to national and institutional guidelines and were approved by the appropriate authority. 
 
Immunohistochemistry and quantification 
Mice were deeply anesthetized and transcardially perfused with 0.9% sodium chloride followed by 4% 
paraformaldehyde (PFA, Otto Fischar GmbH & Co. KG). Brains were removed from the skulls, postfixed in 4% PFA 
at 4°C overnight, and transferred to 30% sucrose. Sequential 40 µm coronal sections were cut on a microtome and 
cryoprotected for long-term storage. For BrdU staining, DNA was denatured in 2N HCl for 20 min at 37°C. Sections 
were rinsed in 0.1 M borate buffer and washed in Tris-buffered saline (TBS). Sections were stained free-floating with 
all antibodies diluted in TBS containing 3% donkey serum and 0.1% Triton X-100. Primary antibodies were applied 
in the following concentrations: anti-BrdU (rat, 1:500; Biozol/AbD serotec), anti-doublecortin (DCX; goat, 1:250; 
Santa Cruz Biotechnology), anti-Sox2 (goat, 1:1000; Santa Cruz Biotechnology), anti-iba1 (rabbit, 1:500; Wako), 
anti-NeuN (rabbit, 1:500; Millipore). For immunofluorescence, Alexa488-conjugated, Cy3-conjugated, or Cy5-
conjugated secondary antibodies (Invitrogen) were used. Immunohistochemistry for BrdU-only followed the 
peroxidase method with biotinylated secondary antibody (Donkey anti-rat Biotin, 1:500, Jackson laboratories), ABC 
Elite reagent (Vector Laboratories), and di-aminobenzidine (DAB; Vector Laboratories) used as chromogen.  
For quantification, one-in-six series of sections of each brain were BrdU stained for light microscopy (peroxidase 
method), and immunoreactive cells were counted throughout the rostro-caudal extent of the dentate gyrus. Results 
were multiplied by six to obtain the total number of BrdU-positive cells per dentate gyrus. For phenotypic analysis, 
one-in-twelve series of sections were labeled for multiple-immunofluorescence staining. Fifty to 100 randomly 
selected cells per animal were evaluated for three-dimensional colocalization using a Leica TCS SP5 (Leica, 
Germany) confocal microscope. 
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RT-PCR 
Another set of animals (n = 12 for WT; n = 3 B1KO, n = 3 B2KO) was used to analyze the expression of B1R and 
B2R in the hippocampus and prefrontal cortex at baseline, and following running using RT-PCR. The designated 
regions of both hemispheres were dissected and pooled, RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, 
CA), and first-strand cDNA was generated using High Capacity cDNA Reverse Transcription kit (Applied 
Biosystems, Carlsbad, CA). The following primers were used: B1R-Forward-5-
TGGAGTTGAACGTTTTGGGTTT-3, B1R-Reverse-5-GTGAGGATCAGCCCCATTGT-3 (GenBank: EY274959), 
B2R-Forward-5-GGTGCTGAGGAACAACGAGA-3, B2R-Reverse-5-CCCAACACAGCACAAAGAGC-3 
(GenBank: EY275228), gapDH-Forward-5-GCTGTGGGCAAGGTCATCC-3 and gapDH-Reverse-5-
CTTCACCACCTTCTTGATGTC-3 (GenBank: XM_017321385). Quantitative PCR was performed with the 
TaqMan system (Applied Biosystems), and the protocol was as follows: 95°C for 10 min, 95°C for 30 s, 60°C for 30 
s, and 72°C for 30 s. Target mRNA expression was normalized to levels of Gapdh using specific primer set obtained 
from BIOTEZ-Berlin. Data are shown as value ΔΔCt and normalized to WT baseline expression. 
 
Statistical analysis 
Statistical significance was evaluated by Two-way analysis of variance (ANOVA) for BrdU numbers followed by 
Tukey’s post hoc tests in cases where a significant F statistics was obtained. For individual comparisons an unpaired 
two-tailed Student’s t-test was used. All values are expressed as mean ± sem. P-values of ≤ 0.05 were considered 
statistically significant.  
 
Results 
B1R is over-expressed in the adult hippocampus in the absence of B2R  
We first quantified B1R and B2R mRNA expression levels in the hippocampus and prefrontal cortex of WT and 
knockout mice (n = 4 WT, n = 3 B1KO, n = 3 B2KO). At baseline, B1R expression is significantly increased in 
B2KO mice in the adult hippocampus (DDCT B1R: WT 1.00 ± 0.145 vs. B2KO 2.400 ± 0.507, p = 0.0478; Fig. 1b); 
a trend was seen in the prefrontal cortex (DDCT B1R: WT 1.00 ± 0.350 vs. B2KO 1.850 ± 0.235, p = 0.1027; Fig. 
1b). No change in mRNA level was observed vice versa for B2R expression in B1KO mice in both hippocampus 
(DDCT B2R: WT 1.00 ± 0.233 vs. B1KO 1.140 ± 0.289, p = 0.6485) and prefrontal cortex (DDCT B2R: WT 1.00 ± 
0.199 vs. B1KO 0.800 ± 0.127, p = 0.3254; Fig. 1b).   
 
B1R expression is downregulated following running 
Following physical exercise for 6 days, B1R expression is significantly downregulated in the hippocampus of WT 
animals (n = 8; DDCT B1R: WT RUN 0.611 ± 0.131, p = 0.0289; Fig. 1b) with no changes observed in the B2R 
expression level (DDCT B2R: WT RUN 0.766 ± 0.378, p = 0.396; Fig. 1b). Receptor expression in the prefrontal 
cortex is not affected by running. WT animals ran the total amount of 47.1 ± 6.3 km in 6 days with a temporal average 
per night of 11.36 ± 0.15 h (Fig. 1c). Knockout mice were running significantly less distances and time compared 
with WT: B1KO (27.1 ± 3.9 Km, p = 0.026; 8.01 ± 0.86 h, p = 0.0065), B2KO (24.5 ± 7.3 km, p = 0.05; 9.40 ± 0.35 
h, p = 0.0005), and B1/2KO (18.3 ± 5.5 km, p = 0.005; 7.76 ± 0.62 h, p = 0.0002, Fig. 1c). Notably, running less was 
reflected by changes in the running performance at night: WT mice ran enduringly at high level all night long, B2KO 
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animals run the first half of the night at highest speed and were satiated during the second half, B1KO mice started 
at high level but run overall at less speed with pauses in between (Fig. 1c).   
 
B2R expression is important for running-induced cell proliferation  
We next determined precursor cell proliferation at baseline and following exercise in knockout (n = 5 for baseline, n 
= 5 for running per receptor knockout) and WT mice (n = 5 for baseline, n = 5 for running). At baseline, absence of 
B1R, or B2R, or both did not alter the number of BrdU-positive cells in the dentate gyrus (Fig. 1d). However, when 
animals were subjected to voluntary wheel running, a condition as well as genotype effect was observed (Two-way 
ANOVA F(1,29)=75.57, p condition < 0.0001; F(3,29)=3.669, p genotype = 0.0235; Fig. 1d). The running stimulus robustly 
increased the number of proliferating cells in WT (baseline 745 ± 104 cells vs. running 2408 ± 209 cells, Tukey’s 
post hoc p < 0.0001), and B1KO animals (baseline 854 ± 112 cells vs. running 2430 ± 302 cells, Tukey’s post hoc p 
< 0.0001; Fig. 1d) although B1KO ran significantly less. In B2KO (and also B1/2KO) running groups, the increase 
in BrdU-positive cells was markedly attenuated and significantly less compared with WT and B1KO (WT vs. B2KO, 
and B1KO vs. B2KO Turkeys post hoc p < 0.05; Fig. 1d). Nevertheless, a statistical significant increase after running 
was reached using Student’s t-test for B2KO (baseline 681 ± 115 cells vs. running 1509 ± 224 cells, p = 0.019) and 
B1/2KO groups (baseline 766 ± 52 cells vs. running 1512 ± 153 cells, p = 0.0006; Fig. 1d).  
 
Assessment of phenotype of newly generated cells  
We next assessed phenotypes of BrdU-positive cells at baseline and following running. Quantification at baseline 
revealed no differences between groups in cell number and ratio for the neural precursor marker Sox2 and the 
transient immature neuronal marker DCX, but decreased co-labeling of BrdU and the nuclear marker NeuN was 
observed in B1/2KO mice compared with WT (ratio 6.9 ± 0.2% v 13.3 ± 2.1% BrdU/NeuN-positive cells, p = 0.049; 
Table 1). Following running, the boost in absolute numbers in WT and B1KO animals was reflected by a significant 
increase in BrdU/Sox2-positive type-2a precursors (3.7-times, WT p = 0.0020, B1KO p < 0.0001) and BrdU/DCX-
positive type-2b/3 immature neurons (2.8-times, WT p = 0.0038, B1KO p < 0.00010). Table 1 –nomenclature by 
(Kempermann et al., 2004); note that up to 3% of BrdU/Sox2-positive cells may overlap with DCX (Steiner et al., 
2006). The number of BrdU/NeuN-positive cells after running was increased by 3.7- (WT; p = 0.0009) and 2.7-times 
(B1KO, p = 0.0111; Table 1), respectively. In B2KO, almost half of BrdU-positive cells after running expressed 
Sox2; which is the largest increase in percentage of all groups (B2KO baseline 35.8 ± 2.0% vs. running 48.8 ± 1.9%, 
p = 0.010). In turn, the number of immature and mature neurons only doubled in B2KO and B1/2KO after running 
and only reached statistical difference for BrdU/DCX in B1/2KO compared with baseline (p = 0.0190; Table 1). We 
have also looked at co-expression of BrdU and the microglia marker Iba-1. Interestingly, after 6 days of running 
significantly more BrdU/Iba1-positive microglia cells were found in B2KO (8-times) and B1/2KO mice (3.9-times; 
Table 1).  
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Table 1 Number and phenotypes of BrdU-positive cells in the SGZ/GCL   
BrdU-positive cells co-expressing Sox2 (precursor cells), DCX (transient immature neurons), NeuN (immature, and 
mature granule cells), iba-1 (microglia), or neither marker are presented. All data are shown as mean ± sem 
 
Baseline Cell number Sox2 DCX NeuN Iba-1 Other 
WT      745 (104) 283 (51) 240 (31) 99 (16) 19 (7) 134 
B1KO      854 (112) 286 (11) 231 (29) 136 (33) 14 (8) 187 
B2KO      681 (115) 214 (37)      156 (9) 89 (38) 7 (4) 215 
B1/2KO      766 (52) 219 (30) 211 (37)      52 (5)# 14 (4) 276 
Running          
WT    2408 (209)**** 1052 (106)**  679 (115)**   366 (51)**  38 (11) 273 
B1KO    2430 (302)****   1061 (55)****    722 (18)**** 370 (76)*  24 (15) 253 
B2KO    1509 (224)    736 (137)*#     352 (117)ƒ    164 (46)#ƒ     57 (9)* 169 
B1/2KO    1512 (153) 581 (102)*# 488 (57)*ƒ   111 (28)##ƒ    55 (11)* 301 
Tukey’s post hoc *p < 0.05, **p < 0.01, ****p < 0.001 to baseline of same genotype, #p < 0.05, ##p < 0.01 to WT 
of same condition, ƒp < 0.05 to B1KO of same condition 
 
Discussion 
Our data demonstrate that B1R and B2R are expressed in the adult mouse hippocampus and prefrontal cortex. 
Furthermore, B1R mRNA expression levels are affected by the running stimulus, and they compensate for the lack 
of B2R in the hippocampus at baseline. Our most prominent result is an attenuation of running-induced precursor cell 
proliferation in the dentate gyrus in the absence of B2R that is accompanied by a shift in cell phenotypes and increased 
microglia numbers.  
Vasoactive kinin peptides are important for blood pressure regulation and inflammation, and also function in the 
brain. On cellular level, B2R immunoreactivity has been described in neurons of the rat hippocampus and olfactory 
bulb; B1R mRNA is expressed throughout the primate brain and spinal cord (Chen et al., 2000, Shughrue et al., 2003). 
Both receptors are upregulated under pathological conditions mediating pro-inflammatory effects (Austinat et al., 
2009, Su et al., 2009), e.g. in temporal lobe epilepsy (Perosa et al., 2007, Silva et al., 2008) or in ischemic stroke 
(Howl and Payne, 2003). However, the receptors differ in their cellular distribution in that B1R is expressed in 
astrocytes, while B2R remains present in neurons in diabetic rats after ischemic stroke (Howl and Payne, 2003). 
Studies pharmacologically targeting the two receptors also revealed differential effects with B1R expression strongly 
responsive to inflammation (Sriramula and Lazartigues, 2017) and to changes in the environment (Ongali et al., 2003, 
Arganaraz et al., 2004). Furthermore, blockade of B1R in rats led to the improvement of cognitive function and age-
related cognitive decline (Prediger et al., 2008, Bitencourt et al., 2017). B2R is crucial in long-term facilitation of 
angiogenesis and neurogenesis (Xia et al., 2006, Trujillo et al., 2012) playing a protective role against cell-death 
(Arganaraz et al., 2004). 
In our study, B1R mRNA is overexpressed in the hippocampus of B2KO mice, probably as compensation for the 
absence of B2R. In mammals, genes encoding both receptors are located in ‘tandem orientation’ on the same 
chromosome (Cayla et al., 2002); compensation of one receptor in lack of the other has been described (Fonseca et 
al., 2013). B1R mRNA expression levels were downregulated in WT animals upon the external running stimulus 
with unaffected cell proliferation in the absence of B1R. In both, WT and B1KO mice the typical robust pro-mitotic 
effect of physical exercise was observed (van Praag et al., 1999). In contrast, B2R mRNA levels were neither affected 
by running nor by the lack of B1R. However, B2R is important to induce precursor cell proliferation in the dentate 
gyrus upon running. Given that no specific antibodies exist to date, we cannot say whether B2R plays a direct or 
indirect role on cell proliferation. Our findings further demonstrate alterations in the number of cells towards a 
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neuronal lineage in B2KO as shown by an elevation in BrdU/Sox2 co-labeling and microglia, while a decrease in 
DCX or NeuN co-expression was observed in comparison to WT. This data substantiates a neuroprotective role for 
B2R. 
We observed changes in running performance for both receptor knockout models in that mice are getting exhausted 
faster. B1KO mice paused often, B2KO almost stopped running for the second half of the night resulting in less 
distances and running time over 6 days. Voluntary running activity was also markedly decreased in a recent study on 
dopamine 2 receptor (D2R) know-down mice due to altered energy expenditure (Beeler et al., 2016). Since B2R-
D2R can function through the formation of a dimer (Niewiarowska-Sendo et al., 2017), D2R activity may participate 
in the observed effect of physically running in B2KO mice. Nevertheless, only in the absence of B2R running-induced 
cell proliferation was affected. Shorter running distances could influence the results on cell proliferation. However, 
it has been shown that running 3 hours during the middle of the night is sufficient to induce the pro-mitotic effect 
(Holmes et al., 2004), as was also seen for B1KO mice. We conclude the neurogenic response to physical exercise is 
at least partially mediated by B2R. Furthermore, the population of BrdU/Iba1-positive microglia is significantly 
increased after running in B2KO mice. Increased Iba1 expression might be a response to increased inflammation 
mediated by amplified ‘inducible’ B1R in B2KO mice; as has been described earlier, when bradykinin-induced 
migration of microglia to the injury site was observed, mediated by upregulation of B1R (Ifuku et al., 2007); yet, our 
results on B1/2KO do not support this.  
Together, our data identify B1R as strongly responsive to changes in the environment, while B2R is necessary on the 
cellular level to induce cell proliferation and fate choice toward a neuronal lineage after physical exercise.  
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Figure legend 
a Experimental design. Wild type [WT] and B1KO, B2KO, B1/2KO mice were randomly assigned to either baseline 
or running groups. Readout: 1) mRNA receptor expression levels, and 2) number of proliferating cells at day 7, 24 
hours after the first of three intraperitoneal injections of BrdU 
b Receptor mRNA expression revealed increased B1R levels in B2KO, and downregulation after running in the 
hippocampus of WT mice; B2R expression was not affected (n = 4 WT, n = 3 B1KO, n = 3 B2KO at baseline; n = 8 
for WT baseline vs. running) 
c Running distances and time was significantly shorter in knockout mice; running performance overnight reveals 
early satiation in B1KO, and exhaustion of B2KO mice during the second half of the night (Representative graphs 
per genotype) 
d Absolute BrdU numbers are unchanged at baseline between genotypes; however, physical exercise significantly 
increased cell proliferation in WT and B1KO and attenuated levels in B2KO, B1/2KO mice (n = 5 per group, 
condition, and genotype); representative images of BrdU-labeled cells after running, SGZ, subgranular zone; Scale 
bar 100 µm 
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